Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): Actions and defects in obesity and type II diabetes

Experimental Biology and Medicine

Volumn 230, Issue 9, 2005, Pages 593-605

  Farese, Robert V ^a   Sajan, Mini P ^a   Standaert, Mary L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atypical protein kinase C; Diabetes; Glucose; Glucose transport; Insulin; Lipids; Liver; Muscle; Obesity; Protein kinase b

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENOSINE PHOSPHATE; GLUCOSE; LOW DENSITY LIPOPROTEIN; METFORMIN; PROTEIN KINASE B; PROTEIN KINASE C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIVER; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 27144450970     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523000901     Document Type: Short Survey

References (67)

1. White MF, Kahn CR. The insulin signaling system. J Biol Chem 269:1-4, 1994.
2. Withers DJ, White M. The insulin signaling system. Endocrinology 141:1917-1921, 2000.
3. Pessin JE, Saltiel AR. Signaling pathways in insulin action. J Clin Invest 106:165-169, 2000.
4. Standaert ML, Kanoh Y, Sajan MP, Bandyopadhyay G, Farese RV. Cbl, IRS-1 and IRS-2 mediate effects of rosiglitazone on phosphatidylinositol (PI) 3-kinase, protein kinase C-λ and glucose transport in 3T3/L1 adipocytes. Endocrinology 143:1705-1716, 2002.
5. Miura A, Sajan MP, Standert ML, Bandyopadhyay G, Franklin DM, Lea-Currie R, Farese RV. Cbl pYXXM motifs activate the p85 subunit of phosphatidylinositol 3-kinase, atypical protein kinase C and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes. Biochemistry 42:14335-14341, 2003.
6. Standaert ML, Sajan MP, Miura A, Bandyopadhyay G, Farese RV. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of PI3K and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes. Biochemistry 43:15494-15502, 2004.
7. Mitra P, Zheng X, Czech MP. RNA-based analysis of CAP, Cbl, and CrkII in the regulation of GLUT4 by insulin. J Biol Chem 279:37431-37435, 2004.
8. Ahn M-Y, Katsanakis KD, Bheda F, Pillay TS. Primary and essential role of the adapter protein APS for recruitment of both c-Cbl and CAP in insulin signaling. J Biol Chem 279:21526-21532, 2004.
9. Matsumoto M, Ogawa W, Akimoto K, Inoue H, Miyaki K, Furukawa K, Hayashi Y, Iguchi H, Marsuki Y, Hiramatsu R, Shimano H, Yamada N, Ohno S, Kasuga M, Noda T. PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 112:935-944, 2003.
10. Bandyopadhyay G, Standaert ML, Sajan MP, Karnitz LM, Cong L, Quon MJ, Farese RV. Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase-C-ζ. Mol Endocrinol 13:1766-1772, 1999.
11. Le Good JA, Ziegler WH, Parakh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045, 1998.
12. Chou MM, How W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhause BS, Toker A. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol 8:1069-1077, 1998.
13. Alessi D, James S, Downes C, Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bζ. Curr Biol 7:261-269, 1997.
14. Egawa K, Maegawa H, Shi K, Nakamura T, Obata T, Yoshizaki T, Morino K, Shimizu S, Nishio Y, Suzuki E, Kashiwagi A. Membrane localization of 3-phosphoinositide-dependent protein kinase-1 stimulates activities of Akt and atypical PKC, but does not stimulate glucose transport and glycogen synthesis in 3T3/L1 adipocytes. J Biol Chem 277:38863-38869, 2002.
15. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active Akt Ser/Thr kinase in 3T3/L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-31378, 1996.
16. Tanti J, Grillo S, Gremeaux T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138:2005-2009, 1997.
17. Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, Woodgett JR, Klip A. Protein kinase B/Akt participates in GLUT4 translocation in L6 myoblasts. Mol Cell Biol 19:4008-4018, 1999.
18. Hill MM, Clark SF, Tucker DF, Birnbaum MJ, James DE, Macaulay SL. A role for protein kinase Bβ/Akt2 in GLUT4 translocation in adipocytes. Mol Cell Biol 19:7771-7781.
19. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Kasuga M. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18:3708-3717, 1998.
20. Cong L, Chen H, Li Y, Zhou L, McGibbon MA, Taylor SI, Qoun MJ. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 11:1881-1889, 1997.
21. Bandyopadhyay G, Sajan MP, Yoshinori Kanoh Y, Standaert ML, Quon MJ, Lea-Currie RL, Sen A, Farese RV. Protein kinases C-ζ mediates insulin effects on glucose transport in cultured human adipocytes. J Clin Endocrinol Metab 87:716-723, 2002.
22. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBζ is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349-38352, 2001.
23. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase AKT2 (PKB-β). Science 292:1728-1731, 2001.
24. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP. Insulin signaling through Akt/PKB analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci U S A 100:7569-7574, 2003.
25. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM. Protein phosphatase 2A negatively regulates insulin's metabolic pathway by inhibiting Akt (protein kinase B) activity in 3T3/L1 adipocytes. Mol Cell Biol 24:8778-87789, 2004.
26. Bae SS, Cho H, Mu J, Birnbaum MJ. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278:49530-49536, 2003.
27. Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L, Karnam P, Moscat J, Farese RV. Activation of protein kinase C (α, β and ζ) by insulin in 3T3/L1 cells: transfection studies suggest a role for PKC-ζ in glucose transport. J Biol Chem 272:2551-2558, 1997.
28. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV. Evidence for involvement of protein kinase C (PKC)-ζ and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138:4721-4731, 1997.
29. Standaert ML, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese RV. Protein kinase C-f as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: potential role in glucose transport. J Biol Chem 272:30075-30082, 1997.
30. Bandyopadhyay G, Standaert ML, Kikkawa U, Ono Y, Moscat J, Farese RV. Effects of transiently expressed atypical (ζ, λ), conventional (α, β) and novel (δ, ε) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-ζ and C-λ. Biochem J 337:461-470, 1999.
31. Kotani K, Ogawa W, Matsumoto M, Kitamura T, Sakaue H, Hino Y, Miyake K, Sano W, Akimoto K, Ohno S, Kasuga M. Requirement of atypical protein kinase Cλ for insulin stimulation on glucose uptake but not for Akt activation in 3T3/L1 adipocytes. Mol Cell Biol 18:6971-6982, 1998.
32. Bandyopadhyay G, Kanoh Y, Sajan MP, Standaert ML, Farese RV. Effects of adenoviral gene transfer of wild-type, constitutively-active, and kinase-defective protein kinase C-ζ on insulin-stimulated glucose transport in L6 myotubes. Endocrinology 141:4120-4127, 2000.
33. Condorelli G, Vigliotta G, Trencia A, Maitan MA, Caruso M, Miele C, Oriente F, Santopietro S, Formisano P, Beguinot F. Protein kinase C(PKC)-ζ activation inhibits PKC-ζ and mediates the action of PED/ PEA-15 on glucose transport in L6 muscle cells. Diabetes 50:1244-1250, 2001.
34. 3 activate PKC-ζ by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry 40:249-255, 2001.
35. Etgen GJ, Valasek KM, Broderick CL, Miller AR. In vivo adenoviral delivery of human protein kinase C-f stimulates glucose transport activity in rat skeletal muscle. J Biol Chem 274:22139-22142, 1999.
36. Bandyopadhyay G, Standaert ML, Sajan MP, Kanoh Y, Miura A, Braun U, Kruse F, Leitges M, Farese RV. Protein kinase C-λ knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. Mol Endocrinol 18:373-383, 2004.
37. Zhou QL, Park JG, Jiang ZY, Holik JJ, Mitra P, Semiz S, Powelka AM, Tang X, Virbasius J, Czech MP. Analysis of insulin signaling by RNAi-based gene silencing. Biochem Soc Trans 32:817-821, 2004.
38. Kanzaki M, Mora S, Hwang JB, Saltiel AR, Pessin JE. Atypical protein kinase C (PKCζ/λ) is a convergent downstream target of insulin-stimulated phosphatidylinositol 3-kinase and TC10 signaling pathways. J Cell Biol 164:279-290, 2004.
39. Standaert ML, Bandyopadhyay G, Perez L, Price D, Galloway L, Poklepovic A, Sajan MP, Cenni V, Sirri A, Moscat J, Toker A, Farese RV. Insulin activates protein kinases C-ζ and C-λ by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem 274:25308-25316, 1999.
40. Sajan MP, Standaert ML, Miura A, Kahn RC, Farese RV. Tissuespecific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver and adipocytes of insulin receptor substrate-1 knockout mice. Mol Endocrinol 18:2513-2521, 2004.
41. Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, Benito M. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52:2239-2248, 2003.
42. Miura A, Sajan MP, Standaert ML, Bandyopadhyay G, Kahn CR, Farese RV. Insulin substrates 1 and 2 are required for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action I immortalized brown adipocytes. Biochemistry 43:15503-15509, 2004.
43. Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV. Thiazolidinedione treatment enhances insulin effects on protein kinase Cζ/κ activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats. J Biol Chem 275:16690-16696, 2000.
44. Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV. Rosiglitazone, insulin treatment and fasting correct defective activation of protein kinase C-ζ by insulin in vastus lateralis muscles and adipocytes of diabetic rats. Endocrinology 142:1595-1605, 2001.
45. Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, Farese RV Jr, Farese RV. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakizaki) liver. J Biol Chem 279:24929-24934, 2004.
46. 3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52:1926-1934, 2003.
47. Kim YB, Kotani K, Ciaraldi TP, Farese RV, Henry RR, Kahn BB. Insulin-stimulated PKC C-λ/ζ activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes. Diabetes 52:1935-1942, 2003.
48. Standaert ML, Ortmeyer HK, Hansen BC, Sajan MP, Kanoh Y, Bandyopadhyay G, Farese RV. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes mellitus in monkeys is linked to a defect in insulin activation of protein kinase C-ζ/λ/ι. Diabetes 51:2936-2943, 2002.
49. 3 in cultured adipocytes and myotubes of obese subjects. J Clin Endocrinol Metab 89:3994-3998, 2004.
50. Hori H, Sasaoka T, Ishihara H, Wadu T, Murakami S, Ishiki M, Kobayashi M. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of db/db mice. Diabetes 51:2387-2394, 2002.
51. Chen HC, Rao M, Sajan MP, Standaert ML, Kanoh Y, Miura A, Farese RV Jr, Farese RV. Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking acyl CoA:diacylglycerol acyltransferase 1. Diabetes 53:1445-1451, 2004.
52. 3 in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes. Endocrinology 144:947-954, 2003.
53. Kim Y-B, Shulman GI, Kahn BB. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C λ/ζ but not on glycogen synthase kinase-3β. J Biol Chem 277:32915-32922, 2002.
54. Kerouz NJ, Horsch D, Pons S, Kahn CR. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997.
55. Anai M, Funaki M, Ogihara T, Kanda A, Onishi Y, Sakoda H, Inukai K, Nawano M, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes 48:158-169, 1999.
56. Laviola L, Belsanti G, Davalli AM, Napoli R, Perrini S, Weir GC, Giorgino R, Giorgino F. Effects of streptozotocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 50:2709-2720, 2001.
57. Bandyopadhyay G, Sajan MP, Kanho Y, Standaert ML, Quon MJ, Reed BC, Dikic I, Farese RV. Glucose activates protein kinase C-ζ/λ through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D. J Biol Chem 276:35537-35545, 2001.
58. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Farese RV Jr, Farese RV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and AICAR-stimulated glucose transport. J Biol Chem 277:23554-23562, 2002.
59. Sajan MP, Bandyopadhyopadhyay G, Kanoh Y, Standaert ML, Quon MJ, Reed BC, Dikic I, Farese RV. Sorbitol activates atypical PKCs and GLUT 4 glucose transporter translocation/glucose transport through PYK2, the ERK pathway and phospholipase D. Biochem J 362:665-674, 2002.
60. Fryer LGD, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226-25232, 2002.
61. Yamouchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295, 2002.
62. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ. Metformin increases AMPK activity in muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081, 2002.
63. Perrini S, Henriksson J, Zierath J, Widegren U. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53:21-24, 2004.
64. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. A role of AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7:1085-1094, 2001.
65. Wojtaszewski JFP, Nielsen JN, Jorgensen SB, Frosig C, Birk JB, Richter EA. Transgenic models-a scientific tool to understand exercise-induced metabolism: the regulatory role of AMPK (5′-AMP-activated protein kinase) in glucose transport and glycogen synthase activity in skeletal muscle. Biochem Soc Trans 31:1290-1294, 2003.
66. Vollenweider P, Menard B, Nicod P. Insulin resistance, defective IRS-2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (ζ/λ) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 51:1052-1059, 2002.
67. Beeson M, Sajan MP, Gomez-Daspet J, Luna V, Dizon M, Grebenev D,. Powe JL, Lucidi S, Miura A, Kanoh Y, Bandyopadhyay G, Standaert ML, Yeko TR, Farese RV. Defective activation of protein kinase C-ζ by insulin and phosphatidylinositol 3-kinase in obesity and polycystic ovary syndrome. Metab Syndr Rel Disord 2:49-56, 2004.